Abstract 15216: Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction and Active Malignancy: A Propensity Matched Retrospective Analysis
Background: Patients living with both heart failure with reduced ejection fraction (HFrEF) and active malignancy represent one of the most challenging populations in modern cardiology. Despite carrying the highest combined cardiovascular and oncologic risk, they have been excluded from every landmark sodium glucose...